The global topical antibiotics market size was valued at USD 6.2 billion in 2023, driven by the rising incidence of infectious diseases across the globe. The market is expected to grow at a CAGR of 3.90% during the forecast period of 2024-2032, with the values likely to rise from USD 6.44 billion in 2024 to USD 8.75 billion by 2032.
Topical antibiotics are used to treat skin infections via direct application on the affected site. They are widely available as creams, gels, and ointments. Topical antibiotics are agents that kill or inhibit the growth of their responsive micro-organisms. They are widely used in several conditions, from infections in cuts and in mild to severe acne cases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing incidence of diseases associated with pathogenic microorganisms has led to significant topical antibiotics market demand in recent years. Moreover, patients that have inadequate hygiene, a weak immune system, and an infected epidermis and close contact with people with epidermal disease are more vulnerable to illness. To combat the rising burden of infectious diseases, the market has flourished with several technical advancements to expediate the drug development process.
With the rising prevalence of multidrug resistance and development of superbugs, the decreased efficacy of antibiotics has been a key area of concern for scientists and researchers. Consequently, new chemical entities have emerged in the market to target the increasing antibiotic resistance issue. A prime example is quinolones, that target bacterial DNA gyrase and topoisomerase IV to achieve the antibacterial effects.
In July 2023, the FDA approved Verrica Pharmaceuticals’ therapy, VP-102 to treat molluscum contagiosum (molluscum) which is a highly contagious viral skin disease, affecting children under 16 years of age. This medication uses a drug-device combination with a controlled formulation of cantharidin (0.7% w/v) and is designed to be administered through a single-use applicator for topical dosing, facilitating targeted delivery. Such developments solidify the ongoing trend of blending non-pharmacological and pharmacological approaches to enable effective results for patients, indicating that the topical antibiotics market value is expected to grow further in the following years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The topical antibiotics market share has been dominated by the North America, specifically United States in the historical period. Extensive research on the assessment of the effectiveness and protection of the generic components used in antibiotics has become a key component of the growth of the regional industry. In addition, the robust research and development infrastructure also contributes to the market value in the region.
Apart from United States, Europe is another significant player in the market. The presence can be accredited to the existence of major research and academic institutions in the region. In addition, the prominent healthcare players also play a critical role in fostering innovation for developing new drugs.
It is estimated that the Asia Pacific region will witness fastest topical antibiotics market growth in the forecast period. The growth can be attributed to the increasing awareness about hygiene and sanitation spread by government as well as private institutions in the region. There is an influx of foreign capital in the region, with major healthcare and pharmaceutical companies setting up research laboratories to use the academic talent and other resources available in the area.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type||
|Breakup by Application||
|Breakup by Distribution Channel||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Topical Antibiotics Market Overview
3.1 Global Topical Antibiotics Market Historical Value (2017-2023)
3.2 Global Topical Antibiotics Market Forecast Value (2024-2032)
4 Global Topical Antibiotics Market Landscape
4.1 Global Topical Antibiotics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Topical Antibiotics Product Landscape
4.2.1 Analysis by Class
4.2.2 Analysis by Applications
5 Global Topical Antibiotics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Topical Antibiotics Market Segmentation
6.1 Global Topical Antibiotics Market by Product Type
6.1.1 Market Overview
6.2 Global Topical Antibiotics Market by Application
6.2.1 Market Overview
6.2.2 Skin Infections
6.2.3 Eye Infections
6.2.4 Ear Infections
6.2.5 Nasal Infections
6.3 Global Topical Antibiotics Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacies
6.3.3 Retail Pharmacies
6.3.4 Online Pharmacies
6.4 Global Topical Antibiotics Market by End User
6.4.1 Market Overview
6.4.4 Ambulatory Surgical Centres
6.4.5 Home Care Settings
6.5 Global Topical Antibiotics Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Topical Antibiotics Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Topical Antibiotics Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Topical Antibiotics Market
9.1 Market Share by Country
10 Latin America Topical Antibiotics Market
10.1 Market Share by Country
11 Middle East and Africa Topical Antibiotics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Clinical Trials Analysis
13.1 Analysis by Trial Registration Year
13.2 Analysis by Trial Status
13.3 Analysis by Trial Phase
13.4 Analysis by Therapeutic Area
13.5 Analysis by Geography
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 F. Hoffmann-La Roche Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Mylan N.V.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Pfizer Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 GlaxoSmithKline plc (GSK)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Novartis AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Bayer AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Merck & Co., Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Sun Pharmaceutical Industries Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Aurobindo Pharma
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Fresenius Kabi AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Akorn Incorporated
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 Teva Pharmaceutical Industries Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.15 AstraZeneca plc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
18 Global Topical Antibiotics Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 6.2 billion in 2023, driven by the increasing prevalence of infectious diseases across the globe.
The market is anticipated to grow at a CAGR of 3.90% during the forecast period of 2024-2032, likely to reach a market value of USD 8.75 billion by 2032.
The market demand is driven by the rising population, growing awareness of treatment options, and increasing rising technological advancements for the development of novel therapeutics.
The current market trend revolves around increased number of drug approvals and the convergence of pharmacological and non-pharmacological techniques for rapid drug development. The FDA approval of Verrica to treat molluscum in children aged above 2 years of age is one such example.
Commonly used products include creams, ointments, gels, lotions, powders, and solutions, among others.
Common applications of the product include skin infections, eye infections, ear infections, and nasal infections, among others.
Major distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
Major end users include hospitals, clinics, ambulatory surgical centres, and homecare settings.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are F. Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., GlaxoSmithKline plc (GSK), Novartis AG, Bayer AG, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Lupin, Fresenius Kabi AG, Akorn Incorporated, Teva Pharmaceutical Industries Ltd., AstraZeneca plc., and Aurobindo Pharma.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.